Lido Advisors
EXAS

Lido Advisors’s Exact Sciences EXAS Stock Holding History

Lido Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,100
Closed -$153K – 1180
2022
Q4 		$153K Buy
+3,100
New +$127K ﹤0.01% 933

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lido Advisors's EXAS Position: Q1 2026 in Review

Lido Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12,382 shares — an estimated $1.11M sold.

Lido Advisors first reported a position in EXAS in Q2 2021 and held it in 15 quarters. The position peaked at $1.36M in Q3 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Lido Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Lido Advisors sold 12,382 Exact Sciences shares in Q1 2026, an estimated $1.11M.
  • Lido Advisors first reported a position in Exact Sciences in Q2 2021 and held it in 15 quarters.
  • Lido Advisors's Exact Sciences position peaked at $1.36M in Q3 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.